BSAC Spring Conference & AGM

Addressing the AMR burden in everyday practice

18-19 May 2023

QEII Conference Centre London & online

Welcome to the BSAC Spring Conference

Welcome to the BSAC Spring Conference & AGM 2023: Addressing the AMR burden in everyday practice

You can view the recorded content from this hybrid conference.

Abstracts from this conference are now published and available to view open access here.

This conference is RCPath CPD accredited.

Programme

SESSION ONE: Emerging, imported and forgotten infections
This video comprises of the following presentations:

Welcome and opening remarks

Dr David Jenkins, University Hospitals of Leicester NHS Trust & BSAC President

Management of imported infections - CPE from Ukranian casualties treated in The Netherlands

Dr Daan Notermans, Medical Microbiologist, Dutch National Institute for Public Health and the Environment (RIVM)

Tuberculosis - programmatic testing and treatment for latent tuberculosis in migrants

Professor Ajit Lalvani, NIHR Health Protection Research Unit in Respiratory Infections, Imperial College London

Group A streptococcus pleural empyema in children

Dr Thomas Christie Williams, Wellcome Trust ECAT Clinical Lecturer, The University of Edinburgh & Registrar in Respiratory Paediatrics at the Royal Hospital for Children, Glasgow

Q&A

SESSION TWO: Recording AMR as primary cause or contributory cause of death
This video comprises of the following presentations:

Balancing the opportunity and risk: the political importance of making this happen

Professor Dame Sally Davies, UK Government Special Envoy on Antimicrobial Resistance, UK Department of Health and Social Care

Death certification and AMR

Dr Alan Fletcher, National Medical Examiner for England and Wales

What education, training and advocacy is now needed?

Dr David Jenkins, University Hospitals of Leicester NHS Trust & BSAC President

Panel discussion

SESSION THREE: Invited lectures
This video comprises of the following presentations:

New models of antimicrobial funding in England

Professor Philip Howard OBE, AMR Regional Antimicrobial Stewardship Lead, NHS England & NHS Improvement - North-East & Yorkshire, UK and immediate Past President, BSAC

UKAR update

Professor Gareth Jones, Professor in Epidemiology at the University of Aberdeen and Co-Chief Investigator of the UK Antimicrobial Registry

Q&A

SESSION FIVE: Fungal infection challenges
This video comprises of the following presentations:

Systemic fungal infections - the stewardship challenges

Ms Laura Whitney, Regional Antimicrobial Stewardship Lead London, NHS England and NHS Improvement

Implementation of an antifungal stewardship program and the impact on a stem cell transplant centre

Mr Richard Wilson, Research Pharmacist, Imperial College London

Candida resistance in the ICU

Dr Tihana Bicanic, Reader & Consultant in Infectious Diseases, St George’s University of London & St George’s Hospital

Q&A

SESSION SEVEN: Keynote Lecture
This video comprises of the following presentations:

Rethinking AMS: New ideas for appropriate access from India

Dr Ramanan Laxminarayan, President of the One Health Trust, Senior Research Scholar, Princeton University

Q&A

SESSION EIGHT: CLINICAL LESSONS
This video comprises of the following presentations:

Understanding the role of accessory genes in AMR phenotype using interpretable machine learning models.

Miss Lucy Dillon, PhD Student, Queen's University Belfast

The consumption of human antibiotics in veterinary medicine, in Estonia, 2006–2022

Mrs Marju Sammul, PhD Student, Estonian University of Life Sciences

Patterns of general practitioner and nurse independent prescriber prescriptions for antibiotics dispensed in the community in England: A retrospective analysis

Professor Molly Courtenay, Cardiff University

Penicillin and cephalosporin cross-reactivity; a single centre UK study

Miss Eve Duke, Pharmacist, Leeds Teaching Hospitals Trust
SESSION NINE: Penicillin allergy de-labelling
This video comprises of the following presentations:

How do we translate policy to practice in the UK

Dr Louise Savic, Leeds Teaching Hospitals

Penfast study - lessons from Australia

Associate Professor Jason Trubiano, Infectious Diseases Physician & NHMRC Early Career Researcher, University of Melbourne, Department of Medicine (Austin Health)

Q&A

SESSION TEN: Invited lecture
This video comprises of the following presentations:

Nothing changes unless it changes: The role of rapid diagnostics in hepatology

Dr Vishal Patel, Consultant Hepatologist, Liver Unit, King's College Hospital London & Principal Investigator, The Roger Williams Institute of Hepatology, Foundation for Liver Research

Q&A

SESSION TWELVE: Sustainability and innovation: Securing the future of antimicrobials
This video comprises of the following presentations:

The post treatment impact of antimicrobials in the environment – a threat to yet be understood?

Professor Will Gaze, University of Exeter

Achieving sustainable antimicrobial usage: exploring the “how” from a systems perspective

Dr Kelly Thornber, Research Fellow, University of Exeter

Confronting a Permacrisis - the intersection between antimicrobial resistance, climate change and biodiversity loss

Mr Tom Tayler, Aviva Investors

Q&A

SESSION FIFTEEN: Alternative approaches and preventative measures
This video comprises of the following presentations:

Phage therapy

Professor Martha Clokie, Professor of Microbiology, University of Leicester

Large scale cohort studies and genomics to understand Staphylococcus aureus colonisation and biology

Dr Ewan Harrison, Wellcome Sanger Institute

Faecal transplants

Professor Mark Wilcox, Leeds Teaching Hospitals NHS Trust

Do it simple, do it well: reducing infection through low cost preventative measures

Professor Tim Walsh, University of Oxford

Q&A

SESSION SIXTEEN: Why promoting patient and public advocacy matters to the AMR narrative
This video comprises of the following presentations:

The AMR Narrative

Ms Vanessa Carter, AMR Patient Survivor & One Health Advocate and Founder, The AMR Narrative

Q&A

Top